Fundraising Fox

ACORN BIOVENTURESFull Portfolio

6 tracked investments · listed companies and verified rows first

Addex Therapeuticsaddextherapeutics.comNASDAQ: ADXNDec 2021SEC filingmedium confidence

Addex Therapeutics is a clinical-stage pharmaceutical company that develops orally available small molecule drugs known as allosteric modulators for neurological disorders.

BiotechHealthtechGeneva

Roger Mills(Executive Officer, Director)Mikhail Kalinichev(Executive Officer)Jean-Philippe Rocher(Executive Officer)Robert Lutjens(Executive Officer)Timothy Dyer(Executive Officer, Director)Vincent Lawton(Director)

Board seatIsaac Manke· per SEC Form D · $5.9M raise · filed Dec 2021

Co-investorsNew Enterprise Associates (NEA)Sofinnova PartnersSR One Capital Management

Onkure Therapeutics Inconkuretherapeutics.comin𝕏NASDAQ: OKUROct 2024SEC filingmedium confidence

OnKure Therapeutics is a clinical-stage biopharmaceutical company developing PI3Kα pan-mutant selective inhibitor medicines for the treatment of breast cancer and vascular anomalies.

BiotechDigital HealthHealthtechMedical DevicesBoulder, US

Jason Leverone(Executive Officer)Samuel Agresta(Executive Officer)Dylan Hartley(Executive Officer)Nicholas Saccomano(Executive Officer, Director)Wendy Johnson(Executive Officer)

Board seatIsaac Manke· per SEC Form D · $65M raise · filed Oct 2024

Co-investorsAccess BiotechnologyRiverVest Venture PartnersAbingworthBoulder VenturesNew Enterprise Associates (NEA)

CG Oncologycgoncology.comin𝕏NASDAQ: CGON

CG Oncology is a clinical-stage biotechnology company developing bladder-sparing oncolytic immunotherapies for patients with bladder cancer.

BiotechHealthtech

Co-investorsDecheng CapitalForesite CapitalLongitude CapitalPalm Drive CapitalRA CapitalTCG Crossover+2 more

OnKure, Inc.Mar 2021SEC filingmedium confidence

Engaged in discovery and development of targeted small molecule therapies for cancer treatment, including selective mutant-specific PI3K inhibitors.

BiotechBoulder, US

Anthony D. Piscopio(Executive Officer, Director)Nicholas Saccomano(Director)Duncan Walker(Executive Officer)James Winkler(Executive Officer)Jason Leverone(Executive Officer)Keith M. Olivia(Executive Officer)

Board seatIsaac Manke· per SEC Form D · $56.6M raise · filed Mar 2022

Co-investorsSamsara BioCapital

Complexicacomplexica.com

Complexica provides artificial intelligence software for supply and demand optimisation, including its Decision Cloud platform and "Larry, the Digital Analyst" engine for promotional planning, pricing, demand forecasting, supply chain scheduling, and sales optimisation.

AI & Machine LearningEnterprise SoftwareLogistics & Supply Chain

Co-investorsPerennial Partners

Redbubbleredbubble.com

Redbubble is an online marketplace where independent artists sell their designs printed on products such as apparel and other merchandise.

Creator EconomyE-commerceMarketplaces

Martin Hosking(Founder)in

Co-investorsBlackbird VenturesPiton Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.